The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Physiological and Functional Basis of Dopamine Receptors and Their Role in Neurogenesis: Possible Implication for Parkinson’s disease
Open accessAbstract
Dopamine controls various physiological functions in the brain and periphery by acting on its receptors D1, D2, D3, D4, and D5. Dopamine receptors are G protein–coupled receptors involved in the regulation of motor activity and several neurological disorders such as schizophrenia, bipolar disorder, Parkinson’s disease (PD), Alzheimer’s disease, and attention-deficit/hyperactivity disorder. Reduction in dopamine content in the nigrostriatal pathway is associated with the development of PD, along with the degeneration of dopaminergic neurons in the substantia nigra region. Dopamine receptors directly regulate neurotransmission of other neurotransmitters, release of cyclic adenosine monophosphate, cell proliferation, and differentiation. Here, we provide an update on recent knowledge about the signalling mechanism, mode of action, and the evidence for the physiological and functional basis of dopamine receptors. We also highlight the pivotal role of these receptors in the modulation of neurogenesis, a possible therapeutic target that might help to slow down the process of neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,725
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats
Altman, J., & Das, G. D. (1965) · Journal of Comparative Neurology · doi:10.1002/cne.901240303 · Cited by 3,592
Non-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807
The prevalence of Parkinson's disease: a systematic review and meta-analysis
Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014) · Movement Disorders · doi:10.1002/mds.25945 · Cited by 2,188
Seeman, P. (1980) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06839-5 · Cited by 1,892
Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes
Castellanos, F. X., & Tannock, R. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn896 · Cited by 1,827
Neurogenesis in the Adult Rat: Electron Microscopic Analysis of Light Radioautographs
Kaplan, M. S., & Hinds, J. W. (1977) · Science · doi:10.1126/science.887941 · Cited by 1,475
The Basal Ganglia and Adaptive Motor Control
Graybiel, A. M., Aosaki, T., Flaherty, A. W., & Kimura, M. (1994) · Science · doi:10.1126/science.8091209 · Cited by 1,324
mTOR signaling: At the crossroads of plasticity, memory and disease
Hoeffer, C. A., & Klann, E. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2009.11.003 · Cited by 1,128
Kebabian, J. W., Petzold, G. L., & Greengard, P. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.8.2145 · Cited by 1,022
Goldman, S. A., & Nottebohm, F. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.8.2390 · Cited by 993
Dopamine depletion impairs precursor cell proliferation in Parkinson disease
Höglinger, G. U., Rizk, P., Muriel, M. P., Duyckaerts, C., Oertel, W. H., Caille, I., & Hirsch, E. C. (2004) · Nature Neuroscience · doi:10.1038/nn1265 · Cited by 944
Boyson, S., McGonigle, P., & Molinoff, P. (1986) · The Journal of Neuroscience · doi:10.1523/jneurosci.06-11-03177.1986 · Cited by 747
Dopamine: A Prolactin-Inhibiting Hormone*
BEN-JONATHAN, N. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-4-564 · Cited by 733
Prevalence and incidence of Parkinson's disease in Europe
von Campenhausen, S., Bornschein, B., Wick, R., Bötzel, K., Sampaio, C., Poewe, W., Oertel, W., Siebert, U., Berger, K., & Dodel, R. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.007 · Cited by 625
Lacey, M. G., Mercuri, N. B., & North, R. A. (1987) · The Journal of Physiology · doi:10.1113/jphysiol.1987.sp016787 · Cited by 614
Evidence for neurogenesis in the adult mammalian substantia nigra
Zhao, M., Momma, S., Delfani, K., Carlén, M., Cassidy, R. M., Johansson, C. B., Brismar, H., Shupliakov, O., Frisén, J., & Janson, A. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1131955100 · Cited by 590
Dopamine receptors and brain function
Jaber, M., Robinson, S. W., Missale, C., & Caron, M. G. (1996) · Neuropharmacology · doi:10.1016/s0028-3908(96)00100-1 · Cited by 570
Brezun, J. M., & Daszuta, A. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00693-9 · Cited by 549
Dopamine receptors: Molecular biology, biochemistry and behavioural aspects
Jackson, D. M., & Westlind-Danielsson, A. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90041-8 · Cited by 483
The Adult Substantia Nigra Contains Progenitor Cells with Neurogenic Potential
Lie, D. C., Dziewczapolski, G., Willhoite, A. R., Kaspar, B. K., Shults, C. W., & Gage, F. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06639.2002 · Cited by 449
Dopamine-Sensitive Adenyl Cyclase: Possible Role in Synaptic Transmission
Kebabian, J. W., & Greengard, P. (1971) · Science · doi:10.1126/science.174.4016.1346 · Cited by 421
Signaling in Adult Neurogenesis
Suh, H., Deng, W., & Gage, F. H. (2009) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.042308.113256 · Cited by 375
Cell therapy in Parkinson’s disease
Lindvall, O., & Björklund, A. (2004) · NeuroRX · doi:10.1602/neurorx.1.4.382 · Cited by 346
Signaling mechanisms regulating adult neural stem cells and neurogenesis
Faigle, R., & Song, H. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.09.002 · Cited by 333
Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390
Savasta, M., Dubois, A., & Scatton, B. (1986) · Brain Research · doi:10.1016/0006-8993(86)90749-3 · Cited by 318
Neural stem cells in mammalian development
Merkle, F. T., & Alvarez-Buylla, A. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.09.008 · Cited by 312
Charles, P. (2002) · Brain · doi:10.1093/brain/awf216 · Cited by 288
Brown, J. H., & Makman, M. H. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.3.539 · Cited by 287
Le, W.-D., Rowe, D., Xie, W., Ortiz, I., He, Y., & Appel, S. H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08447.2001 · Cited by 275
Spano, P., Govoni, S. M., & Trabucchi, M. (1978) · PubMed · Cited by 262
No evidence for new dopaminergic neurons in the adult mammalian substantia nigra
Frielingsdorf, H., Schwarz, K., Brundin, P., & Mohapel, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401229101 · Cited by 251
Brami-Cherrier, K., Valjent, E., Garcia, M., Pagès, C., Hipskind, R. A., & Caboche, J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08911.2002 · Cited by 230
A Paradigm Shift in Brain Research
Carlsson, A. (2001) · Science · doi:10.1126/science.1066969 · Cited by 221
Kippin, T. E. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1120-05.2005 · Cited by 213
Neuronal cell death in Huntington’s disease: a potential role for dopamine
Jakel, R. J., & Maragos, W. F. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01568-x · Cited by 197
Parkinson's disease: from brain homogenate to treatment.
Hornykiewicz, O. (1973) · PubMed · Cited by 178
Emir, U. E., Tuite, P. J., & Öz, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030918 · Cited by 176
Dopamine receptor activation promotes adult neurogenesis in an acute Parkinson model
Winner, B., Desplats, P., Hagl, C. M., Klucken, J., Aigner, R., Ploetz, S., Laemke, J., Karl, A., Aigner, L., Masliah, E., et al. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.013 · Cited by 175
Serotonin and Parkinson's disease: On movement, mood, and madness
Fox, S. H., Chuang, R., & Brotchie, J. M. (2009) · Movement Disorders · doi:10.1002/mds.22473 · Cited by 175
Brazel, C. Y., Nuñez, J. L., Yang, Z., & Levison, S. W. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.10.038 · Cited by 169
Comparison of the distribution of D-1 and D-2 dopamine receptors in the rat brain.
Wamsley, J. K., Gehlert, D. R., Filloux, F. M., & Dawson, T. M. (1989) · PubMed · Cited by 168
Van Kampen, J. M., Hagg, T., & Robertson, H. A. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03342.x · Cited by 167
Cooper, O., & Isacson, O. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2344-04.2004 · Cited by 167
Mohapel, P., Frielingsdorf, H., Häggblad, J., Zachrisson, O., & Brundin, P. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.11.056 · Cited by 163
Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro
Ogawa, N., Tanaka, K.-I., Asanuma, M., Kawai, M., Masumizu, T., Kohno, M., & Mori, A. (1994) · Brain Research · doi:10.1016/0006-8993(94)90969-5 · Cited by 160
Freundlieb, N., François, C., Tandé, D., Oertel, W. H., Hirsch, É. C., & Höglinger, G. U. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4859-05.2006 · Cited by 155
D 2 -Like Dopamine Autoreceptor Activation Reduces Quantal Size in PC12 Cells
Pothos, E. N., Przedborski, S., Davila, V., Schmitz, Y., & Sulzer, D. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-15-05575.1998 · Cited by 153
Preclinical pharmacology of ropinirole (SK&F 101468-A) a novel dopamine D2 agonist
Eden, R. J., Costall, B., Domeney, A. M., Gerrard, P. A., Harvey, C. A., Kelly, M. E., Naylor, R. J., Owen, D. A. A., & Wright, A. E. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90603-y · Cited by 146
Curtis, M. A., Low, V. F., & Faull, R. L. M. (2012) · Developmental Neurobiology · doi:10.1002/dneu.22028 · Cited by 143
A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson’s disease
Korczyn, A. D., Brunt, E. R., Larsen, J. O., Nagy, Z., Poewe, W. H., & Ruggieri, S. A. (1999) · Neurology · doi:10.1212/wnl.53.2.364 · Cited by 142
Possibility for neurogenesis in substantia nigra of parkinsonian brain
Yoshimi, K., Ren, Y., Seki, T., Yamada, M., 大泉, 英., Onodera, M., Saito, Y., Murayama, S., Okano, H., Mizuno, Y., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20506 · Cited by 140
Prevalence of Parkinson's Disease in the Parsi Community of Bombay, India
Bharucha, N. E., Bharucha, E. P., Bharucha, A. E., Bhise, A. V., & Schoenberg, B. S. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520360039008 · Cited by 137
Selective D-1 dopamine receptor agonist treatment of parkinson's disease
Braun, A., Fabbrini, G., Mouradian, M. M., Serrati, C., Barone, P., & Chase, T. N. (1987) · Journal of Neural Transmission · doi:10.1007/bf01244638 · Cited by 134
Kampen, J. M. V., & Eckman, C. B. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0837-06.2006 · Cited by 133
Autoradiographic localization of D1 and D2 dopamine receptors in the human brain
Keyser, J. D., Claeys, A., Backer, J. D., Ebinger, G., Roels, F., & Vauquelin, G. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90758-6 · Cited by 127
CHEN, Y., AI, Y., SLEVIN, J., MALEY, B., & GASH, D. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.07.010 · Cited by 126
Díaz, J., Ridray, S., Mignon, V., Griffon, N., Schwartz, J., & Sokoloff, P. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-11-04282.1997 · Cited by 124
Nishi, A., Snyder, G. L., Nairn, A. C., & Greengard, P. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722015.x · Cited by 120
Kim, S. Y., Choi, K. C., Chang, M. S., Kim, M., Kim, S. Y., Na, Y.-S., Lee, J. E., Jin, B. K., Lee, B., & Baik, J. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5236-05.2006 · Cited by 107
Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model
Kohl, Z., Winner, B., Ubhi, K., Rockenstein, E., Mante, M., Münch, M., Barlow, C., Carter, T., Masliah, E., & Winkler, J. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07933.x · Cited by 101
Kampen, J. M. V., & Robertson, H. A. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.07.054 · Cited by 101
Kay, J. N., & Blum, M. (2000) · Developmental Neuroscience · doi:10.1159/000017427 · Cited by 95
Hermann, A., Maisel, M., Wegner, F., Liebau, S., Kim, D., Gerlach, M., Schwarz, J., Kim, K., & Storch, A. (2005) · Stem Cells · doi:10.1634/stemcells.2005-0192 · Cited by 94
Mao, L., Lau, Y., Petroske, E., & Wang, J. Q. (2001) · Developmental Brain Research · doi:10.1016/s0165-3806(01)00260-7 · Cited by 94
The effect of dopamine on adult hippocampal neurogenesis
Takamura, N., Nakagawa, S., Masuda, T., Boku, S., Kato, A., Song, N., An, Y., Kitaichi, Y., Inoue, T., Koyama, T., et al. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.12.011 · Cited by 92
Transient elevation of adult hippocampal neurogenesis after dopamine depletion
Park, J., & Enikolopov, G. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.01.004 · Cited by 83
Onali, P., Olianas, M. C., & Bunse, B. (1988) · Brain Research · doi:10.1016/0006-8993(88)90232-6 · Cited by 71
Singh, S., Mishra, A., Srivastava, N., Shukla, R., & Shukla, S. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0293-5 · Cited by 71
Self-citationSuzuki, K., Okada, K., Wakuda, T., Shinmura, C., Kameno, Y., Iwata, K., Takahashi, T., Suda, S., Matsuzaki, H., Iwata, Y., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009260 · Cited by 69
Regulation of Na+, K+ ‐ATPase Isoforms in Rat Neostriatum by Dopamine and Protein Kinase C
Nishi, A., Fisone, G., Snyder, G. L., Dulubova, I., Aperia, A., Nairn, A. C., & Greengard, P. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731492.x · Cited by 69
la Cour, C. M., Salles, M., Pasteau, V., & Millan, M. J. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.065409 · Cited by 66
Reducing central serotonin in adulthood promotes hippocampal neurogenesis
Song, N., Jia, Y., Zhang, L., Zhang, Q., Huang, Y., Liu, X., Hu, L., Lan, W., Chen, L., Lesch, K., et al. (2016) · Scientific Reports · doi:10.1038/srep20338 · Cited by 65
Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
Konitsiotis, S., & Bargiotas, P. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s36693 · Cited by 62
Singh, S., Mishra, A., Bharti, S., Tiwari, V., Singh, J., Parul, P., & Shukla, S. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0860-4 · Cited by 60
Self-citationRogers, J., Vo, U., Buret, L., Pang, T. Y., Meiklejohn, H., Zeleznikow-Johnston, A., Churilov, L. P., van den Buuse, M., Hannan, A. J., & Renoir, T. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.52 · Cited by 55
D3 dopamine receptors do not regulate neurogenesis in the subventricular zone of adult mice
Baker, S. A., Baker, K. A., & Hagg, T. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.01.004 · Cited by 52
Salvi, R., Steigleder, T., Schlachetzki, J. C. M., Waldmann, E., Schwab, S., Winner, B., Winkler, J., & Kohl, Z. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00077 · Cited by 50
Glutamate and Regulation of Proliferation in the Developing Mammalian Telencephalon
Luk, K. C., & Sadikot, A. F. (2004) · Developmental Neuroscience · doi:10.1159/000082139 · Cited by 47
Wang, Y.-Y., Wang, Y., Jiang, H., Liu, J.-H., Jia, J., Wang, K., Zhao, F., Luo, M., Luo, M., & Wang, X. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.11.006 · Cited by 44
Zhang, T., Hong, J., Di, T., & Chen, L. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00101 · Cited by 43
Reimers, D., Herranz, A. S., Díaz-Gil, J. J., Lobo, M. V. T., Paíno, C. L., Alonso, R. L., Asensio, M. J., Gonzalo‐Gobernado, R., & Bazán, E. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5a6805.2005 · Cited by 42
Singh, S., Mishra, A., & Shukla, S. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9361-5 · Cited by 41
Self-citationNeurogenic potential of progenitor cells isolated from postmortem human Parkinsonian brains
Wang, S., Okun, M. S., Suslov, O. N., Zheng, T., McFarland, N. R., Vedam‐Mai, V., Foote, K. D., Roper, S. N., Yachnis, A. T., Siebzehnrübl, F. A., et al. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.039 · Cited by 41
Singh, S., Mishra, A., Srivastava, N., & Shukla, S. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00354 · Cited by 40
Self-citationMembrane properties of identified mesencephalic dopamine neurons in primary dissociated cell culture
Chiodo, L. A., & Kapatos, G. (1992) · Synapse · doi:10.1002/syn.890110405 · Cited by 38
The Gilles de la Tourette Syndrome
Robertson, M. M., & Stern, J. S. (1997) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v11.i1.10 · Cited by 37
Ha, C. M., Park, D., Han, J.-K., Jang, J.-I., Park, J., Hwang, E. M., Seok, H., & Chang, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.370601 · Cited by 37
Hedlund, E., Belnoue, L., Theofilopoulos, S., Saltó, C., Bye, C. R., Parish, C. L., Deng, Q., Kadkhodaei, B., Ericson, J., Arenas, E., et al. (2016) · Scientific Reports · doi:10.1038/srep26448 · Cited by 37
Wegner, F., Kraft, R., Busse, K., Schaarschmidt, G., Härtig, W., Schwarz, S. C., & Schwarz, J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06315.x · Cited by 32
Singh, S., Mishra, A., Mishra, S. K., & Shukla, S. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.05.017 · Cited by 31
Self-citationLong-term treatment with dopamine agonists in idiopathic in Parkinson's disease
Reichmann, H. (2000) · Journal of Neurology · doi:10.1007/pl00007768 · Cited by 29
Buchanan, R. J., Darrow, D., Meier, K. T., Robinson, J., Schiehser, D. M., Glahn, D. C., & Nádasdy, Z. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00081 · Cited by 27
Konieczny, J., Czarnecka, A. M., Lenda, T., Kamińska, K., & Lorenc‐Koci, E. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.12.019 · Cited by 25
Ermine, C. M., Wright, J. L., Frausin, S., Kauhausen, J. A., Parish, C. L., Stanić, D., & Thompson, L. H. (2018) · Hippocampus · doi:10.1002/hipo.22835 · Cited by 23
Tuura, R., Baumann, C. R., & Baumann‐Vogel, H. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.02.014 · Cited by 21
Gomes, P., & Soares-da-Silva, P. (2002) · Cellular Physiology and Biochemistry · doi:10.1159/000067896 · Cited by 12
Cited by
Dopamine in Parkinson's disease
Latif, S., Jahangeer, M., Maknoon Razia, D., Ashiq, M., Ghaffar, A., Akram, M., El Allam, A., Bouyahya, A., Garipova, L., Ali Shariati, M., et al. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.08.009 · Cited by 340
Revisiting the role of neurotransmitters in epilepsy: An updated review
Akyuz, E., Polat, A. K., Eroglu, E., Kullu, I., Angelopoulou, E., & Paudel, Y. N. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118826 · Cited by 303
Opioid Analgesia and Opioid-Induced Adverse Effects: A Review
Paul, A. K., Smith, C. M., Rahmatullah, M., Nissapatorn, V., Wilairatana, P., Spetea, M., Gueven, N., & Dietis, N. (2021) · Pharmaceuticals · doi:10.3390/ph14111091 · Cited by 300
Nimgampalle, M., Chakravarthy, H., Sharma, S., Shree, S., Bhat, A. R., Pradeepkiran, J. A., & Devanathan, V. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101994 · Cited by 207
Metadata
- Authors
- Mishra, A., Singh, S., & Shukla, S.
- Venue
- Journal of Experimental Neuroscience
- Publisher
- SAGE Publications
- Published
- 2018-01-01
- Volume
- 12
- Pages
- 1179069518779829-1179069518779829
- ISSN
- 1179-0695 (ISSN-L)
- OpenAlex
- W2807135302
- Cited by
- 276
- References
- 99
- FWCI
- 9.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.